BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MUJHU Research Collaboration - ECPv5.12.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MUJHU Research Collaboration
X-ORIGINAL-URL:https://www.mujhu.org
X-WR-CALDESC:Events for MUJHU Research Collaboration
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230512T074500
DTEND;TZID=UTC:20230512T130000
DTSTAMP:20260428T100507
CREATED:20230505T112540Z
LAST-MODIFIED:20230505T150014Z
UID:9729-1683877500-1683896400@www.mujhu.org
SUMMARY:Vaccines in Pregnancy and Infancy: National Stakeholders Meeting
DESCRIPTION:The Makerere University-Johns University Research Collaboration (MU-JHU) in partnership with St Georges University London (SGUL) is inviting you to a special stakeholder meeting to discuss current study findings and future vaccine research in pregnant women and infants in Uganda. \nThe investigators will present updates on current studies within the portfolio and proposed vaccine and observational studies. You will be given an opportunity to ask questions and discuss issues related to vaccination in pregnancy and infancy. \nSeveral studies have been underway with your support since 2018 to set the scene for maternal and infant vaccine clinical trials in Uganda. These include: \n\nThe PROGRESS study\, to determine the incidence of Group B Streptococcal disease (GBS)\, colonization and neurodevelopmental impairment following infant disease. This study also includes a comprehensive overview of other pathogens that cause disease in the first months of life for which vaccines are or will soon be available to be given to pregnant women or their infants. This study will complete follow up in September 2023.\nThe WOMANPOWER study\, to determine the safety and efficacy of a pertussis-containing vaccine (TDaP) given to pregnant women living with HIV. This study has completed and interim results are available.\nThe PREPARE studies: This includes the development of a pregnancy exposures registry and background rates of adverse events in sentinel sites that has also been used to monitor adverse events in pregnancy and infancy during the COVID-19 pandemic (periCOVID study). Pfizer Multivalent CPS-conjugate vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. Minervax GBS vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. This programme of work also includes a large component of vaccine hesitancy work. Updates will be presented on progress to date.\n\nWe will also take the opportunity to update you on upcoming studies within the portfolio and seek your input. These include: \n\nMeasles remains a common cause of morbidity and mortality in infants under five years worldwide\, with occurrence substantially noted in regions with low vaccination rates. While it is generally believed infants are protected by maternal antibodies for 6-9 months\, an over representation of infants under 6 months has been shown in recent outbreaks. Vaccination of infants earlier than the standard 9months with a booster dose may confer protection to these children earlier.BoostME trial: Earlier prime-boost schedule to improve measles protection in\nhigh burden settings.\nA study to investigate risk factors that could be incorporated into routine care to prevent severe infant infection in the first days of life.The studies are conducted at the Several KCCA facilities including Kawempe National Referral Hospital\, Kisenyi health centre IV\, Kawala and Komomboga and others by investigators from MU-JHU and SGUL through the EDCTP\, Medical Research Council and Bill and Belinda Gates Foundation funding.\n\nSession facilitators\n\nProf. Kirsty Le Doare\nDr. Eve Nakabembe\nDr. Robert Mboizi\nDr. Solomon Kamurari\nDr. Hannah Davis\nDr. Ouma Joseph\nDr. Geoff Kitson\nDr. Mary Kyohere\nDr. Alexander Amone\nDr. Gerald Businge\nDr. Lauren Hookham\nDr. Agnes Ssali\nVictoria Nambasa\nAnthony Ssebagereka\nEsther Imede\nSarah Sturrock\nPhiona  Nalubega\nRitah Namugumya\n\nJoin Zoom Meeting:\nhttps://us02web.zoom.us/j/88596947058?pwd=SHFUOHljTnpHMWxKd0VjcmR5emsrQT09\nMeeting ID: 885 969
URL:https://www.mujhu.org/event/vaccines-in-pregnancy-and-infancy-national-stakeholders-meeting/
ATTACH;FMTTYPE=image/jpeg:https://www.mujhu.org/wp-content/uploads/2023/05/PREPARE-meeting-poster-scaled.jpg
ORGANIZER;CN="MU-JHU%20Care%20Ltd":MAILTO:rmboizi@mujhu.org
END:VEVENT
END:VCALENDAR